Your browser doesn't support javascript.
Reduction of early surgical site and other care related infections in 3553 hip fracture patients: lessons learned from the 5-year Safe Hands project.
Erichsen Andersson, Annette; Gillespie, Brigid M; Karlsson, Magnus; Malchau, Henrik; Nellgård, Bengt; Wikström, Ewa; Rogmark, Cecilia; Tillander, Jonatan.
  • Erichsen Andersson A; Institute of Health Care Sciences, Sahlgrenska Academy, University of Gothenburg, Box 457, 405 30, Gothenburg, Sweden. annette.erichsen.andersson@gu.se.
  • Gillespie BM; Department of Orthopedics, Sahlgrenska University Hospital, Gothenburg, Sweden. annette.erichsen.andersson@gu.se.
  • Karlsson M; NHMRC Centre of Research Excellence in Wiser Wounds, Menzies Health Institute, Queensland, Griffith University & Gold Coast University Hospital and Health Service, Queensland, Australia.
  • Malchau H; Department of Orthopedics, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Nellgård B; Department of Orthopedics, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Wikström E; Swedish Hip Arthroplasty Register, Registercentrum VGR, Gothenburg, Sweden.
  • Rogmark C; Department of Anesthesiology and Intensive Care Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Tillander J; Department of Business Administration, School of Business, Economics and Law, University of Gothenburg, Gothenburg, Sweden.
Antimicrob Resist Infect Control ; 11(1): 113, 2022 09 05.
Article in English | MEDLINE | ID: covidwho-2224305
ABSTRACT

BACKGROUND:

Surgical site infection (SSI) after acute hip fracture surgery is a devastating complication associated with increased suffering and mortality. The aim of the study was to investigate early SSI, sepsis, pneumonia and urinary tract infections over five years, before and after the implementation of the Safe Hands project.

METHODS:

This was a single-centre observational study with a 5-year longitudinal design, investigating the effects of an infection-prevention intervention targeting the clinical care pathway of individuals with acute hip fracture. Statistical analyses were based on routinely collected patient outcome data comprising 3553 patients. The study conforms to the criteria of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE).

RESULTS:

The incidence of early SSIs decreased from 2.5% in years 1-2 to 1.1% in years 4-5. Similar results were observed for sepsis (2.7% to 1.3%) and urinary tract infections (14.2% to 4.2%). The multivariable regression results suggest that, for every observed year, the odds of early SSIs decreased. Male gender, procedure time, sepsis and preoperative skin damage increased the odds significantly.

CONCLUSIONS:

Our preventive bundle, based on partnership between researchers, managers and clinicians and a strong commitment to change from the involved professions, appear to be effective in reducing the frequency of potentially devastating SSIs and other hospital acquired infections after hip fracture surgery. The use of external and internal facilitators was crucial to enable individual and organisational learning and overcoming barriers to improvements. TRIAL REGISTRATION Clinical Trials.gov ID NCT02983136 Registered 6 December 2016-Retrospectively registered.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Urinary Tract Infections / Sepsis / Hip Fractures Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans / Male Language: English Journal: Antimicrob Resist Infect Control Year: 2022 Document Type: Article Affiliation country: S13756-022-01153-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Urinary Tract Infections / Sepsis / Hip Fractures Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans / Male Language: English Journal: Antimicrob Resist Infect Control Year: 2022 Document Type: Article Affiliation country: S13756-022-01153-4